DALLAS SEMICONDUCTOR CORP
10-Q, 1995-05-16
SEMICONDUCTORS & RELATED DEVICES
Previous: CASH ACCUMULATION TRUST, NSAR-A, 1995-05-16
Next: OIS OPTICAL IMAGING SYSTEMS INC, 8-K, 1995-05-16




                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C.  20549

                                    FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE 
    SECURITIES EXCHANGE ACT OF 1934
    For the quarterly period ended   April 2, 1995
                                     ---------------

                                       OR

[ ] TRANSITION REPORT  PURSUANT TO SECTION 13 OR 15(d) OF THE 
    SECURITIES EXCHANGE ACT OF 1934
    For the transition period from           to 
                                  ----------    ------------
    Commission file number   1-10464  
                             -------


                       DALLAS SEMICONDUCTOR CORPORATION     
           ------------------------------------------------------
           (Exact name of registrant as specified in its charter)

              Delaware                               75-1935715
              --------                               ----------
   (State or other jurisdiction of      (I.R.S. Employer Identification No.)
   incorporation or organization)       

        
           4401 South Beltwood Parkway, Dallas, Texas 75244-3292 
           -----------------------------------------------------
            (Address of principal executive offices)  (Zip Code)


      Registrant's telephone number, including area code:  (214) 450-0400
                                                           --------------

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.

                                               Yes    X       No 
                                                   -------       --------

Number of shares outstanding of the registrant's Common Stock as of 
May 7, 1995:  25,994,821.
              ----------



<PAGE>  2            
                    DALLAS SEMICONDUCTOR CORPORATION
                           INDEX TO FORM 10-Q


PART I.     FINANCIAL INFORMATION
- -------     ---------------------
Item 1.     FINANCIAL STATEMENTS                                    Page No.
- -------     ------------------------------------------------------  --------
 Condensed Consolidated Statements of Income (Unaudited)
  Three months ended April 2, 1995 and April 3, 1994 ...................3

 Condensed Consolidated Balance Sheets
  April 2, 1995 (Unaudited) and January 1, 1995 ........................4
 
 Condensed Consolidated Statements of Cash Flows (Unaudited)  
  Three months ended April 2, 1995 and April 3, 1994 ...................5 

 Notes to Condensed Consolidated Financial Statements ............. 6 - 7
 
Item 2.     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
- -------     ----------------------------------------
            FINANCIAL CONDIDTION AND RESULTS OF OPERATIONS  ...... 8 - 10
            ----------------------------------------------    

PART II.    OTHER INFORMATION
- --------    ------------------
Items 1. through 6.  ................................................. 11
- ------------------

SIGNATURE ............................................................ 12
- ---------

<PAGE> 3

PART I.     FINANCIAL INFORMATION

Item 1.     Financial Statements
- -------     ---------------------


                        DALLAS SEMICONDUCTOR CORPORATION
                   CONDENSED CONSOLIDATED STATEMENTS OF INCOME

                                   (Unaudited)


                                                  Three months ended  
                                                  ------------------- 
                                                  Apr. 2,     Apr. 3,  
(Thousands except per share amounts)               1995         1994   
- ------------------------------------              -------     -------  
Net sales                                         $52,035     $43,183      
Operating costs and expenses:
 Cost of sales                                     26,045      21,331
 Research and development                           6,532       5,253    
 Selling, general and administrative                7,905       6,284   
                                                  -------     -------  
 Total                                             40,482      32,868  
                                                  -------     -------  
Operating income                                   11,553      10,315 
Interest income, net                                  733         798  
                                                  -------     -------  
Income before income taxes                         12,286      11,113  
Provision for income taxes                          4,116       3,779  
                                                  -------     -------  
Net income                                        $ 8,170     $ 7,334  
                                                  =======     =======  
Net income per share                              $   .30     $   .27  
                                                  =======     =======  
Weighted average common and common
equivalent shares outstanding                      27,243      27,414  
                                                  =======     =======  

Dividends declared per share                      $  .025     $    --
                                                  =======     =======

See accompanying notes.



<PAGE> 4 
                          DALLAS SEMICONDUCTOR CORPORATION
                        CONDENSED CONSOLIDATED BALANCE SHEETS

                                                  Apr. 2,    Jan. 1,
(Thousands except per share amounts)                1995       1995
- -----------------------------------------------  ---------  ---------
                                                 (unaudited)      
Assets

Current assets:
 Cash and cash investments                       $ 65,824    $ 64,520    
 Accounts receivable, net                          30,046      28,330
 Inventories                                       45,125      40,453
 Deferred tax assets                                2,629       2,561
 Other current assets                               3,178       3,730
                                                 --------    --------
Total current assets                              146,802     139,594
 
Property, plant and equipment, at cost:
 Land                                               6,088       5,400
 Building and improvements                         30,495      28,617
 Machinery and equipment                          133,632     130,216
                                                 --------    --------
                                                  170,215     164,233
Less accumulated depreciation                     (90,298)    (85,391)
                                                 --------    --------
   Property, plant and equipment, net              79,917      78,842

Other assets                                        3,340       2,791
                                                 --------    --------
                                                 $230,059    $221,227
                                                 ========    ========

Liabilities and Stockholders' Equity

Current liabilities:
 Accounts payable                                $ 13,168    $ 14,827
 Accrued salaries and benefits                      4,786       5,328
 Accrued taxes other than income                      932       2,486
 Other accrued liabilities                          2,178       2,712
 Income taxes payable                               4,710       1,121
                                                 --------    --------
 Total current liabilities                         25,774      26,474

Stockholders' equity:
 Preferred stock, $0.10 par value;
    5,000,000 shares authorized; no shares
    issued and outstanding                           ---         ---
 Common stock, $0.02 par value; 40,000,000
    shares authorized; issued:
    25,942,004 shares at April 2, 1995, and
    25,575,586 shares at January 1, 1995              519         511
 Additional paid-in capital                        81,153      80,562
 Retained earnings                                123,488     115,962
 Treasury stock, shares at cost:
    55,625 shares at April 2, 1995, and
    153,900 shares at January 1, 1995                (875)     (2,282) 
                                                 --------    --------
 Total stockholders' equity                       204,285     194,753
                                                 --------    --------
                                                 $230,059    $221,227
                                                 ========    ========
See accompanying notes.


<PAGE>  5

                     DALLAS SEMICONDUCTOR CORPORATION
              CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

                                (Unaudited)

                                                  Three Months Ended
                                                 ---------------------
                                                  Apr. 2,      Apr. 3,
(Thousands)                                        1995         1994
- --------------------------------------------     --------    --------
Cash flows from operating activities:
Net income                                       $  8,170     $ 7,334
Adjustments to reconcile net income to net
 cash provided by operating activities:
 Depreciation and amortization                      4,907       3,297
 Deferred tax benefit                                 (68)       (347)
 Increase in receivables                           (1,716)       (917)
 Increase in inventories                           (4,672)       (590)
 Decrease (increase) in other current assets          552          (9)
 (Decrease) increase in accounts payable           (1,659)      1,605
 Decrease in accrued salaries and benefits           (542)       (784)
 Decrease in accrued taxes other than income       (1,554)       (807)
 Decrease in other accrued liabilities               (534)       (206)
 Increase in income taxes payable                   4,138       2,699
                                                 --------    --------
Net cash provided by operating activities           7,022      11,275
                                                 ---------   --------
Cash flows from investing activities:
Additions to property, plant and equipment         (5,982)     (8,708)
(Increase) decrease in other assets                  (549)         70
                                                 --------    --------
Net cash used by investing activities              (6,531)     (8,638)
                                                 --------    --------

Cash flows from financing activities:
Proceeds from issuance of stock 
 upon exercise  of stock options                    1,877         440
Purchase of treasury stock                           (420)         --
Dividend paid to shareholders                        (644)         --
                                                 --------    --------
Net cash provided by financing activities             813         440
                                                 --------    --------
Net increase in cash and cash investments           1,304       3,077
Cash and cash investments at beginning of
  period                                           64,520      76,273
                                                 --------    --------
Cash and cash investments at end of period       $ 65,824    $ 79,350
                                                 ========    ========
Cash payments for:
  Interest                                       $     --    $      6
  Income taxes                                   $     47    $  1,426
 
Supplementary schedule of non-cash financing activities:
  Reduction of income tax payable and increase 
  in paid-in capital resulting from the tax benefit 
  of stock option exercises                       $   549    $    367

See accompanying notes.


<PAGE> 6
                         DALLAS SEMICONDUCTOR CORPORATION
                 NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                    (Unaudited)
    
The accompanying condensed consolidated financial statements have not
been audited by independent auditors, except for the balance sheet as
of January 1, 1995. In the opinion of the Company's management, the
accompanying financial statements reflect all adjustments (consisting only
of normal recurring accruals) necessary to present fairly the Company's
financial position at April 2, 1995 and January 1, 1995,and results of
operations and cash flows for the periods presented.

Certain footnote information has been condensed or omitted from these
financial statements. Therefore, these financial statements should be read
in conjunction with the financial statements and related notes included in
the Company's 1994 Annual Report, which statements and notes were
incorporated by reference in the Company's Annual Report on Form 10-K for
the year ended January 1, 1995. Results of operations for the three
months ended April 2, 1995 are not necessarily indicative of results to be
expected for the full year.

During the quarter ended April 2, 1995, the Company classified its cash 
investments as current. Amortized cost of such investments approximates
their fair market values. Accordingly, all of the Company's investments are
presented as current assets and balances as of January 1, 1995 have been 
reclassified to conform to the April 2, 1995 presentation.

The difference between primary and fully diluted net income per share 
was not material in any period.


                                                April 2,      Jan. 1,
2. INVENTORIES (in thousands)                    1995           1995
                                               --------      ---------
Raw materials                                  $  6,923       $  5,596
Work-in-process                                  25,244         23,727
Finished goods                                   12,958         11,130
                                               --------       --------
                                               $ 45,125       $ 40,453
                                               ========       ========

Inventories are stated at the lower of standard cost, which approximates 
actual cost (first-in, first-out), or market.
 

<PAGE>  7
                  DALLAS SEMICONDUCTOR CORPORATION
           NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                             (Unaudited)

3.  INCOME TAXES
The provision for income taxes includes estimated federal and state income 
taxes at statutory rates and a deferred tax benefit of $68,000 and $347,000
for the first quarter of 1995 and 1994, respectively. Company's effective 
tax rate was 33.5% in the three months ended April 2, 1995, decreasing from 
34.0% for the same period in 1994. This decrease was a result of changes 
in anticipated differences between income for financial statement purposes 
and taxable income for the two periods.

<PAGE>  8
DALLAS SEMICONDUCTOR CORPORATION


Item 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF
         FINANCIAL CONDITION AND RESULTS OF OPERATIONS

RESULTS OF OPERATIONS
- ---------------------
Net sales for the first quarter of 1995 were $52,035,000 an increase of 
20% over the first quarter of 1994.  The Company's revenue growth is 
supported by increased unit sales of new and existing products in several 
product families including Telecommunications, System Extension, 
Microcontrollers, NV SRAMs, Silicon Timed Circuits, and other product 
families.

Gross margins remained relatively constant in the first quarter of 1995, 
decreasing to 50% from 51% in the first quarter of 1994.

Research and development ("R&D") expenses for the first quarter of
1995 increased 24% from the first quarter of 1994.  The increase resulted
primarily from increased personnel costs due to increased headcount.  
R&D expenses as a percent of sales increased from 12% in the first quarter 
of 1994 to 13% in the first quarter of 1995.

Selling, general and administrative ("SG&A") expenses for the first quarter 
of 1995 increased 26% compared with the first quarter of 1994.  The 
increase in SG&A expenses resulted primarily from increased sales commission 
amounts due to higher net sales, increased personnel costs and increased 
advertising expenditures.

Operating income for the first quarter of 1995 increased 12% over the same
period in 1994.  Operating income as a percent of sales decreased in the 
first quarter of 1995 to 22% from 24% in the first quarter of 1994.   The 
decrease resulted from higher first quarter 1995 operating expenses as a
percent of net sales.

Net interest income decreased by $65,000 in the first quarter of 1995 
compared with the first quarter of 1994.  The decrease resulted primarily 
from lower average cash balances during the first quarter of 1995.  Changes 
in interest rates will continue to affect net interest income as will any 
substantial change in the amount of the Company's cash and cash 
investments or borrowings.

<PAGE>  9

The provision for income taxes includes estimated federal and state income 
taxes at statutory rates and a deferred tax benefit of $68,000 and $347,000 
in the first quarter of 1995 and 1994, respectively. The Company's effective 
tax rate decreased from 34.0% in the first quarter of 1994 to 33.5% in the 
first quarter of 1995. This decrease was a result of changes in anticipated 
differences between income for financial statement purposes and taxable 
income for the two periods.

A number of uncertainties exist that may influence the Company's future 
operating results, including general economic conditions, changes in 
conditions affecting original equipment manufacturers, competition 
(including alternative technologies), the Company's success in developing 
new products and process technologies, market acceptance of the Company's 
new products, the ability of the Company to continue diversifying its 
product line, manufacturing performance, availability and price 
fluctuations of raw materials, and other factors.

FINANCIAL CONDITION
- -------------------
Cash and cash investments were $65.8 million at the end of the first 
quarter of 1995, compared with $64.5 million at the end of fiscal year 
1994. The Company continued investing in financial instruments having 
maturities in excess of one year in order to obtain yields higher than 
those available in the short-term market.

Gross capital additions were $6.0 million in the first quarter of 1995,
compared with $8.7 million in the same period of 1994.  The decrease is
primarily the result of lower wafer fabrication facility capital expenditures
in the first quarter of 1995 compared with the first quarter of 1994.

In February 1995, the Company purchased two buildings adjacent to its 
facility in Dallas for $1.6 million, increasing the Company's owned 
building space to approximately 392,000 square feet and land to 26.4 
acres. Capital expenditures for 1995, estimated at approximately $40 
million including the building purchase, is expected to be for wafer 
fabrication, manufacturing and test equipment, and computer hardware and 
software.

<PAGE>  10
In 1994 the board of directors authorized the purchase from time-to-time,
depending on market conditions, up to 500,000 shares of the Company's 
common stock. As of April 2, 1995, a total of 180,000 shares, totalling 
$2,703,000 have been purchased pursuant to this stock repurchase program. 
In the first quarter of 1995, 125,000 of these treasury shares were 
issued to fund employee stock option exercises.

On March 1, 1995, a $.025 dividend was paid on each outstanding share of 
common stock to shareholders of record on February 15, 1995, totalling
$644,000. On April 26, 1995 a $.025 dividend was declared on each 
outstanding share of common stock, payable on June 1, 1995, to shareholders 
of record on May 15, 1995.

The Company had no long-term debt at the end of the first quarter of 1995 
or at the end of fiscal 1994.

<PAGE>  11
DALLAS SEMICONDUCTOR CORPORATION

PART II. OTHER INFORMATION
- --------------------------
Items 1.- 5.
- ------------   
 Not applicable.

Item 6.  Exhibits and Reports on Form 8-K
- -----------------------------------------
  (a)    Exhibit 27 - Financial Data Schedule
         ------------------------------------
            None.
  (b)    Reports on Form 8-K
         -------------------
            No Reports on Form 8-K were filed during the period
            for which this report is filed.

<PAGE>  12
DALLAS SEMICONDUCTOR CORPORATION

SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the 
registrant has duly caused this report to be signed on its behalf by the 
undersigned, thereunto duly authorized.

DALLAS SEMICONDUCTOR CORPORATION


By:       /s/ Alan P. Hale
         ----------------
          Alan P. Hale
          Vice President, Finance
                     
Date:    May 16, 1995
         ------------


<TABLE> <S> <C>

<ARTICLE>             5
<MULTIPLIER>          1,000
       
<S>                                        <C>
<PERIOD-TYPE>                           3-MOS
<FISCAL-YEAR-END>                 DEC-31-1995
<PERIOD-END>                      APR-02-1995
<CASH>                                 65,824
<SECURITIES>                                0
<RECEIVABLES>                          30,046
<ALLOWANCES>                                0
<INVENTORY>                            45,125
<CURRENT-ASSETS>                      146,802
<PP&E>                                170,215
<DEPRECIATION>                         90,298
<TOTAL-ASSETS>                        230,059
<CURRENT-LIABILITIES>                  25,774
<BONDS>                                     0
<COMMON>                                  519
                       0
                                 0
<OTHER-SE>                            204,285
<TOTAL-LIABILITY-AND-EQUITY>          230,059
<SALES>                                52,035
<TOTAL-REVENUES>                       52,035
<CGS>                                  26,045
<TOTAL-COSTS>                          40,482
<OTHER-EXPENSES>                            0
<LOSS-PROVISION>                            0
<INTEREST-EXPENSE>                          0
<INCOME-PRETAX>                        12,286
<INCOME-TAX>                            4,116
<INCOME-CONTINUING>                         0
<DISCONTINUED>                              0
<EXTRAORDINARY>                             0
<CHANGES>                                   0
<NET-INCOME>                            8,170
<EPS-PRIMARY>                             .30
<EPS-DILUTED>                               0
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission